cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nevro Corp
2 own
2 watching
Current Price
$23.48
$-4.04
(-14.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
838.1M
52-Week High
52-Week High
53.34
52-Week Low
52-Week Low
22.12
Average Volume
Average Volume
1.58M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization838.1M
icon52-Week High53.34
icon52-Week Low22.12
iconAverage Volume1.58M
iconDividend Yield--
iconP/E Ratio--
What does the Nevro Corp do?
Nevro Corp., a medical device company, focuses on providing products for the patients suffering from chronic pain in the United States and internationally. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.
Read More
How much money does Nevro Corp make?
News & Events about Nevro Corp.
Benzinga
1month ago
Latest Ratings for NVRO DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform View More Analyst Ratings for NVRO View the Latest Analyst Ratings read more...
Ticker Report
2 months ago
NeuroPace (NASDAQ:NPCE Get Rating) and Nevro (NYSE:NVRO Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk...
Ticker Report
3 months ago
Shares of Nevro Corp. (NYSE:NVRO Get Rating) have received a consensus rating of Hold from the fifteen research firms that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, seven have issued a...
Benzinga
3 months ago
read more...
PR Newswire
4 months ago
Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results PR Newswire REDWOOD CITY, Calif., Jan. 19, 2023 Company to Host Conference Call on Thursday, February 16, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif...
Frequently Asked Questions
Frequently Asked Questions
What is Nevro Corp share price today?
plus_minus_icon
Can Indians buy Nevro Corp shares?
plus_minus_icon
How can I buy Nevro Corp shares from India?
plus_minus_icon
Can Fractional shares of Nevro Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Nevro Corp stocks?
plus_minus_icon
What is today’s traded volume of Nevro Corp?
plus_minus_icon
What is today’s market capitalisation of Nevro Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Nevro Corp?
plus_minus_icon
What percentage is Nevro Corp down from its 52-Week High?
plus_minus_icon
What percentage is Nevro Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$23.48
$-4.04
(-14.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Mesoblast
Mesoblast
$3.60
$-0.06 (-1.64 %)
Coherus BioSciences Inc
Coherus BioSciences Inc
$5.27
$0.29 (5.82 %)
bluebird bio, Inc.
bluebird bio, Inc.
$3.73
$0.02 (0.54 %)
Xencor Inc
Xencor Inc
$27.11
$0.15 (0.56 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Mesoblast
Mesoblast
$3.60
$-0.06 (-1.64 %)
Coherus BioSciences Inc
Coherus BioSciences Inc
$5.27
$0.29 (5.82 %)
bluebird bio, Inc.
bluebird bio, Inc.
$3.73
$0.02 (0.54 %)
Xencor Inc
Xencor Inc
$27.11
$0.15 (0.56 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00